Market Introduction
Over the counter (OTC) drugs are available for the public for their general use. These drugs do not require a prescription from a physician. OTC medicines are available for various medical symptoms due to medical conditions such as coughs and colds, diarrhea, heartburn, constipation, acne, pain, and others. On the other hand, dietary supplements are available over the counter for fitness purposes. Whereas, in some cases, when a person is critically ill or requires treatment, then buying a dietary supplement with medicinal ingredients requires a prescription from a physician. These OTC drugs and nutritional supplements have two type, such as branded or generic.
Market Overview and Dynamics
The Asia PacificOTC Drug and Dietary Supplementmarketis expected to reach US$ 96,156.8 million in 2027 from US$ 55,157.2 million in 2019. The market is anticipated to grow with a CAGR of 7.3% from 2020 to 2027. Factors driving the market growth include rising awareness among population about general health issues, and advantages of OTC drugs are expected to propel the growth of the market. However, stringent government regulation for OTC drugs is the major factor hindering the market growth. COVID19 has affected the Asia Pacific countries which has led to high number of coronavirus cases. People are purchasing more immunity booster products available in the market to combat coronavirus effect
Key Market Segments
In terms of product, the analgesicssegment held the largest share of the market in 2019; however, the vitamins and dietary supplementssegment is anticipated to register the highest CAGR in the market during the forecast period. In terms of type, the generic segment held a larger share of the market in 2019and similarsegment is estimated to register a higher market sharein the market during the forecast period. Likewise, in terms of form, the in tabletssegment held a larger share of the market in 2019 and is estimated to register a higher CAGR in the market during the forecast period. In terms of distribution channel hospital and retail pharmacies held the largest share of market in 2019: however, the online channels segment is anticipated to register the highest CAGR in the market during forecast period.
Major Sources and Companies Listed
The World Health Organization (WHO), World Heart Federation, National Center for Biotechnology Information Therapeutic Goods Administration are some of the major primary and secondary sources for the Asia PacificOTC drug and dietary supplement market included in the report.
Reasons to buy the report
- To understand the Asia PacificOTC drug and dietary supplement market landscape and identifymarket segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for the Asia PacificOTC drug and dietary supplement market
- Efficiently plan M&A and partnership dealsin the Asia PacificOTC drug and dietary supplement market by identifying market segments with the most promising probable sales
- Helps to takeknowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the Asia PacificOTC drug and dietary supplement market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in the region
Asia Pacific OTC Drug and Dietary Supplement Market Segmentation
OTC drug and Dietary Supplement– By Product
- Cough and Cold Products
- Vitamins and Dietary Supplements
- Analgesics
- Gastrointestinal Products
- Sleep Aids
- Oral Care Products
- Ophthalmic Products
- Antacids
- Feminine Care
- Others
OTC Drug and Dietary Supplement – By Type
- Branded
- Generic
OTC Drug and Dietary Supplement – By Form
- Tablets
- Capsules
- Powders
- Ointments
- Liquid
- Others
OTC Drug and Dietary Supplement – By Distribution Channel
- Hospital and Retail Pharmacies
- Retail Stores
- Online Channels
- Others
By Country
- India
- China
- Japan
- Australia
- South Korea
CompanyProfiles
- GlaxoSmithKline plc.
- Sanofi
- Johnson and Johnson Services, Inc.
- Abbott
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Procter & Gamble
- Novartis AG
- Reckitt Benckiser Group Plc